Kurtis D. Davies
University of Colorado Boulder · 184 works · 4,765 citations · h-index 27
Top works
- Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
- Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer
- Molecular Pathways: ROS1 Fusion Proteins in Cancer
- The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
- Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer
- Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples
- Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer
- METExon 14 Skipping Mutations in Non–Small-Cell Lung Cancer: An Overview of Biology, Clinical Outcomes, and Testing Considerations
- Dual Mechanism of a Natural CaMKII Inhibitor
- DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer
- Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices
- Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors
- CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
- Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation
- EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases
- Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers
- Radiation Induces Acute Alterations in Neuronal Function
- Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer
- Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors
- Targetable molecular alterations in congenital glioblastoma